Velan (VLN) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
3 Feb, 2026Executive summary
Q1 fiscal 2025 sales grew 14.5% year-over-year to $77.5M, driven by strong North American and Italian operations and major project deliveries.
Order backlog reached $528.3M, up $36.8M from the start of the year, with 70.5% deliverable in the next 12 months.
Bookings increased 19.6% year-over-year to $109.8M, with a book-to-bill ratio of 1.42 for the quarter.
Gross margin exceeded 30%, supported by higher sales volume and production efficiency.
Signed a CA$50M, 10-year alliance with Bruce Power, strengthening position in the nuclear sector.
Financial highlights
Sales totaled $77.5M, up 14.5% from Q1 fiscal 2024, with gross profit at $23.8M (30.7% margin) versus $15.1M (22.2%) last year.
Adjusted EBITDA was $3.9M, up from -$3.3M last year, reflecting improved profitability.
Adjusted net loss was $1M ($0.05/share), improved from $7.9M ($0.37/share) last year.
Net loss narrowed to $1.1M ($0.05/share) from $8.3M ($0.38/share) in Q1 FY24.
Cash flow from operations was $4.9M, down from $10.7M a year ago, mainly due to less favorable working capital changes.
Cash and equivalents stood at $35.8M, with $5.7M in short-term investments and $24.8M in long-term debt as of May 31, 2024.
Outlook and guidance
Sales growth is expected for fiscal 2025, supported by a strong backlog and 70.5% of orders deliverable within 12 months.
Anticipates benefiting from a decade-long nuclear power growth cycle, especially in North America and Europe, driven by global demand and legislative support.
Latest events from Velan
- Bookings and backlog improved, supporting growth and cash flow focus for 2025.VLN
AGM 20243 Feb 2026 - Bookings and sales soared, backlog reached $548.1M, and net income turned positive.VLN
Q2 202519 Jan 2026 - Strong backlog, major asset sale, and ownership transition marked Q3 2026.VLN
Q3 202615 Jan 2026 - Q3 saw 18.1% sales growth, margin gains, and risk reduction from major divestitures.VLN
Q3 202510 Jan 2026 - Shareholders approved the $201.1 million sale of French subsidiaries to Framatome.VLN
EGM 202526 Dec 2025 - Sales and margins surged, with divestitures and a special dividend boosting future prospects.VLN
Q4 202524 Nov 2025 - 18.6% sales growth, margin gains, and record cash drive a higher dividend and strong outlook.VLN
Q1 202616 Nov 2025 - Strong growth, risk reduction, and strategic expansion defined the year, with all motions approved.VLN
AGM 202516 Nov 2025 - Q2 sales fell 13%, but backlog and liquidity rose, supporting growth in key sectors.VLN
Q2 202612 Oct 2025